Literature DB >> 27915466

Impedance and admittance control for respiratory-motion compensation during robotic needle insertion - a preliminary test.

Yeoun Jae Kim1, Jong Hyun Seo1, Hong Rae Kim1, Kwang Gi Kim1.   

Abstract

BACKGROUND: Many robotic needle-biopsy systems have been developed to enhance the accuracy of needle-biopsy intervention. These systems can reduce the intervention time and the radiation exposure of clinicians. However, respiratory-motion compensation is needed to ensure the accuracy and efficiency of needle biopsy intervention.
METHODS: Human respiratory-motion data were acquired using three inertial measurement units (IMUs), and respiratory motion was simulated using the Stewart-Gough platform. Robotic needle intervention was performed using impedance and admittance control algorithms for respiratory-motion compensation using the Stewart-Gough platform and a gelatin phantom.
RESULTS: The impedance and admittance control algorithms can be used to compensate for respiratory motion during robotic needle insertion. The admittance control algorithm exhibits better performance than the impedance control algorithm.
CONCLUSIONS: The impedance and admittance control algorithms can be applied for respiratory-motion compensation during robotic needle insertion. However, further study is needed for them to become clinically feasible.
Copyright © 2016 John Wiley & Sons, Ltd.

Entities:  

Keywords:  Stewart-Gough platform; admittance control; biopsy; impedance control; respiratory-motion compensation; robotic needle insertion

Mesh:

Year:  2016        PMID: 27915466     DOI: 10.1002/rcs.1795

Source DB:  PubMed          Journal:  Int J Med Robot        ISSN: 1478-5951            Impact factor:   2.547


  1 in total

1.  Radiological and clinical differences between robotic-assisted pedicle screw fixation with and without real-time optical tracking.

Authors:  Jinpeng Du; Lin Gao; Dageng Huang; Lequn Shan; Wentao Wang; Yong Fan; Dingjun Hao; Liang Yan
Journal:  Eur Spine J       Date:  2020-10-20       Impact factor: 3.134

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.